Nationwide Fund Advisors - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 81 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 1.33 and the average weighting 0.8%.

Quarter-by-quarter ownership
Nationwide Fund Advisors ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2017$1,160,000
+501.0%
105,664
+396.0%
0.01%
+400.0%
Q2 2017$193,000
-73.4%
21,302
-62.3%
0.00%
-66.7%
Q1 2017$726,000
+276.2%
56,527
+175.8%
0.00%
+200.0%
Q4 2016$193,000
+28.7%
20,496
+33.3%
0.00%0.0%
Q3 2016$150,000
+4.9%
15,372
-27.7%
0.00%0.0%
Q2 2016$143,000
+4.4%
21,258
+38.3%
0.00%0.0%
Q1 2016$137,000
-32.8%
15,3720.0%0.00%0.0%
Q4 2015$204,000
+29.9%
15,372
+3.1%
0.00%0.0%
Q3 2015$157,000
-61.3%
14,9050.0%0.00%
-50.0%
Q2 2015$406,000
+22.3%
14,905
+37.3%
0.00%
+100.0%
Q1 2015$332,000
-14.4%
10,859
+4.9%
0.00%
-50.0%
Q4 2014$388,000
+7.5%
10,355
+0.1%
0.00%0.0%
Q3 2014$361,000
-18.3%
10,345
+8.9%
0.00%0.0%
Q2 2014$442,000
+41.7%
9,498
-5.9%
0.00%
+100.0%
Q1 2014$312,000
+6.8%
10,095
-20.7%
0.00%0.0%
Q4 2013$292,00012,7320.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q4 2014
NameSharesValueWeighting ↓
Delphi Management Partners VIII, L.L.C. 2,263,006$13,170,0009.51%
Palo Alto Investors LP 5,383,052$31,329,0001.89%
Birchview Capital, LP 246,000$1,432,0000.97%
Rubric Capital Management LP 3,375,758$19,647,0000.55%
Lombard Odier Asset Management (Switzerland) SA 1,517,804$8,834,0000.55%
RICE HALL JAMES & ASSOCIATES, LLC 1,401,861$8,159,0000.30%
AlphaCentric Advisors LLC 136,000$792,0000.20%
Bridgefront Capital, LLC 20,946$122,0000.13%
Hennion & Walsh Asset Management, Inc. 407,474$2,371,0000.12%
Virtus ETF Advisers LLC 44,364$258,0000.11%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders